Abstract:Estrogen deficiency is a seminal mechanism in the pathogenesis of osteoporosis. Mounting evidence, however, establishes that cellular senescence, a fundamental mechanism that drives multiple age‐related diseases, also causes osteoporosis. Recently, we systematically identified an accumulation of senescent cells, characterized by increased p16Ink4a and p21Cip1 levels and development of a senescence‐associated secretory phenotype (SASP), in mouse bone/marrow and human bone with aging. We then demonstrated that elimination of senescent cells prevented age‐related bone loss using multiple approaches, e.g., treating old mice expressing a "suicide" transgene, INK‐ATTAC, with AP20187 to induce apoptosis of p16Ink4a‐senescent cells or periodically treating old wild‐type mice with "senolytics" – i.e., drugs that eliminate senescent cells. Here, we investigate a possible role for estrogen in the regulation of cellular senescence using multiple approaches. First, sex steroid deficiency two‐months post ovariectomy (OVX, n=15) or orchidectomy (ORCH, n=15) versus sham surgery (SHAM, n=15/sex) in young adult (4‐month‐old) wild‐type mice did not alter senescence biomarkers or induce a SASP in bone. Next, in elderly postmenopausal women, three weeks of estrogen therapy (n=10; 74±5 yrs) as compared to no treatment (n=10; 78±5 yrs) did not alter senescence biomarkers or induce a SASP in human bone biopsies. Finally, young adult (4‐month‐old) female INK‐ATTAC mice were randomized (n=17/group) to SHAM+Vehicle, OVX+Vehicle, or OVX+AP20187 for two months. As anticipated, OVX+Vehicle caused significant trabecular/cortical bone loss as compared to SHAM+Vehicle. However, treatment with AP20187, which eliminates senescent cells in INK‐ATTAC mice, did not rescue the OVX‐induced bone loss or alter senescence biomarkers. Collectively, our data establish independent roles of estrogen deficiency and cellular senescence in the pathogenesis of osteoporosis, which has important implications for testing novel senolytics for skeletal efficacy, as these drugs will need to be evaluated in preclinical models of aging as opposed to the current FDA model of prevention of OVX‐induced bone loss.This article is protected by copyright. All rights reserved.

Accelerated Aging in Cyclophilin B-Deficient Mice Downstream of p21-Cip1/Waf1

Cyclophilin D Knock-Out Mice Show Enhanced Resistance to Osteoporosis and to Metabolic Changes Observed in Aging Bone

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

p21 induces a senescence program and skeletal muscle dysfunction

Pleiotropic effects of a recessive C mutation occurring in a mouse model of severe osteogenesis imperfecta

Collagenase-resistant collagen promotes mouse aging and vascular cell senescence.

Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.

Bone-Specific Overexpression of PITX1 Induces Senile Osteoporosis in Mice Through Deficient Self-Renewal of Mesenchymal Progenitors and Wnt Pathway Inhibition

Connexin 43 Channels in Osteocytes Are Necessary for Bone Mass and Skeletal Muscle Function in Aged Male Mice.

Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans

DNA damage drives accelerated bone aging via an NF-κB-dependent mechanism

Cyclophilin D, regulator of the mitochondrial permeability transition, impacts bone development and fracture repair

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model

Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging

Inhibition of CERS1 in skeletal muscle exacerbates age-related muscle dysfunction

REGγ Deficiency Promotes Premature Aging Via the Casein Kinase 1 Pathway.

CD137 Regulates Bone Loss via the p53 Wnt/β-Catenin Signaling Pathways in Aged Mice

A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging

Aging impairs the osteocytic regulation of collagen integrity and bone quality

Examining Tissue Composition, Whole-Bone Morphology and Mechanical Behavior of GorabPrx1 Mice Tibiae: A Mouse Model of Premature Aging

mtDNA release promotes cGAS-STING activation and accelerated aging of postmitotic muscle cells